NASDAQ •
Healthcare •
Medical Devices •
Quote as of 07/07/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.54 mln
Float0.88 mln
Earnings Date08/07/2026
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
0.02
Debt-free
ROE
-150
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Bluejay Diagnostics is a Massachusetts-based medical testing company founded in 2015. Its main product is the Symphony platform, a system that uses a handheld analyzer and disposable cartridges to quickly measure important biological markers in blood samples. The company currently offers a test for tracking inflammation in critically ill patients and is working to expand its offerings to include testing for heart attacks and heart failure.
